SpringWorks Therapeutics, Inc.

SpringWorks Therapeutics, Inc.
Locations Update This Record Cases by Outcome Cases by Type	SEC CIK 1773427

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

SpringWorks Therapeutics, Inc. has not been involved in any litigation in the PlainSite database.

Inside Counsel (0)

Go Pro to view corporate inside counsel.

Outside Counsel (6)

	Last Name	First Name	Middle Name	Firm	Location
				Blank Rome LLP	Washington, DC
		II-VI		Blank Rome LLP	New York, NY
	Labarge	Elizabeth			NEW YORK, NY
	Lessler	Jay		Blank Rome LLP	Philadelphia, PA
	Ll	Blank	Rome		Washington, DC
	Trinque	Brian		Lathrop Gpm Llp	BOSTON, MA

6 Rows Total

Filter By Form All Records 10-Q 3 4 424B4 8-A12B 8-K CERT CORRESP D DRS DRS/A DRSLTR EFFECT S-1 S-1/A S-8 SC 13D SC 13G SEC STAFF UPLOAD From To

	Date	Entity	Form Number	Description
	11/12/2025		SCHEDULE 13G/A
	8/13/2025		SCHEDULE 13G
	8/8/2025		SCHEDULE 13G
	7/11/2025		15-12G
	7/7/2025		SCHEDULE 13G
	7/2/2025	Edris, Badreddin	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Lynch, Daniel	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Lewis-Hall Freda C	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Hambleton, Julie	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Fuhrman Alan	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Lin, Tai-an	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Ashar Bhavesh	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Cassidy, James	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Mackay Martin	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Alban Carlos	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Nofi Michael	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Pichl Daniel	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Francis Perier I Jr	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Islam Saqib	4	Statement of changes in beneficial ownership of securities
	7/2/2025	Weinstein Herschel S	4	Statement of changes in beneficial ownership of securities
	7/1/2025		S-8 POS
	7/1/2025		S-8 POS
	7/1/2025		S-8 POS
	7/1/2025		S-8 POS
	7/1/2025		S-8 POS
	7/1/2025		S-8 POS
	7/1/2025		S-8 POS
	7/1/2025		POSASR
	7/1/2025		8-K	Current report pursuant to Section 13 or 15(d)
	7/1/2025		25-NSE
	6/26/2025		8-K	Current report pursuant to Section 13 or 15(d)
	6/16/2025		DEFA14A
	6/16/2025		8-K	Current report pursuant to Section 13 or 15(d)
	5/28/2025		DEFM14A
	5/15/2025		PREM14A
	5/15/2025	Lynch, Daniel	4	Statement of changes in beneficial ownership of securities
	5/15/2025	Lewis-Hall Freda C	4	Statement of changes in beneficial ownership of securities
	5/15/2025	Hambleton, Julie	4	Statement of changes in beneficial ownership of securities
	5/15/2025	Fuhrman Alan	4	Statement of changes in beneficial ownership of securities
	5/15/2025	Alban Carlos	4	Statement of changes in beneficial ownership of securities
	5/15/2025	Mackay Martin	4	Statement of changes in beneficial ownership of securities
	5/14/2025		8-K	Current report pursuant to Section 13 or 15(d)
	5/9/2025		10-Q
	5/7/2025		SCHEDULE 13G/A
	4/28/2025		DEFA14A
	4/28/2025		DEFA14A
	4/28/2025		8-K	Current report pursuant to Section 13 or 15(d)
	4/4/2025		DEFA14A
	4/4/2025		DEF 14A
	4/4/2025		ARS

457 Rows Total	Page 1 of 10 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	1/10/2025	Mapkure, LLC	Assignee	Application Publication	18966838 20250090507	Methods of Treating Cancer With a B-RAF Inhibitor Methods of Treating Cancer With a B-RAF Inhibitor
	1/10/2025	Sarapa, Nenad	Assignor	Application Publication	18966838 20250090507	Methods of Treating Cancer With a B-RAF Inhibitor Methods of Treating Cancer With a B-RAF Inhibitor
	12/8/2024	Glaxosmithkline Intellectual Property De...	Assignor	Application Application Publication Publication	17602434 17602434 20220168417 20220168417	Combination Therapy With An Anti Bcma Antibody And A Gamma Secretase Inh... Combination Therapy With An Anti Bcma Antibody And A Gamma Secretase Inh...
	11/21/2024	Hatcher, Mark	Assignor	Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent	11504354 17995031 11612588 11807611 18304202 17937283 18490993 17995031 20230091415 20240058307 20240217937 20070078451 20240217937 20070158749 20080296871 20230312480 8277444 7935997	Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Synthesis Of Nirogacestat Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions
	11/21/2024	Patterson, Kristin	Assignor	Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent	18490993 17995031 17995031 11504354 11612588 11807611 18304202 17937283 20240217937 20070078451 20070158749 20080296871 20230312480 20230091415 20240058307 20240217937 8277444 7935997	Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Synthesis Of Nirogacestat Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions
	11/21/2024	Hatcher, Mark	Assignor	Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent	18304202 18490993 17937283 17995031 17995031 11504354 11612588 11807611 20240217937 20240217937 20070078451 20070158749 20080296871 20230312480 20240058307 20230091415 8277444 7935997 12234210	Synthesis Of Nirogacestat Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat
	11/21/2024	Patterson, Kristin	Assignor	Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent	18304202 18490993 17937283 17995031 17995031 11504354 11612588 11807611 20230091415 20240217937 20240217937 20070078451 20070158749 20080296871 20230312480 20240058307 8277444 7935997 12234210	Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Synthesis Of Nirogacestat
	11/21/2024	Hatcher, Mark	Assignor	Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent	17937283 17995031 18304202 18490993 11504354 11612588 11807611 17995031 20230312480 20240058307 20070078451 20070158749 20080296871 20240217937 20230091415 20240217937 12247012 12234210 8277444 7935997	Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Chlorinated Tetralin Compounds And Pharmaceutical Compositions Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Synthesis Of Nirogacestat Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat
	11/21/2024	Patterson, Kristin	Assignor	Application Application Application Application Application Application Application Application Publication Publication Publication Publication Publication Publication Publication Publication Patent Patent Patent Patent	18304202 18490993 11504354 11612588 11807611 17995031 17937283 17995031 20070158749 20080296871 20240217937 20230091415 20240217937 20230312480 20240058307 20070078451 12247012 12234210 8277444 7935997	Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit... Chlorinated Tetralin Compounds And Pharmaceutical Compositions Treatment Of Atrial Fibrillation By Overlapping Curvilinear Lesions Chlorinated Tetralin Compounds And Pharmaceutical Compositions Synthesis Of Nirogacestat Synthesis Of Nirogacestat Telescopic assembly of shoe Low Resistance Peripheral Contacts While Maintaining Dram Array Integrit...
	10/7/2024	Patterson, Kristin	Assignor	Application Publication	18908159 20250025446	Treatments With Nirogacestat Treatments With Nirogacestat
	10/7/2024	Cheng, Shinta	Assignor	Application Publication	18908159 20250025446	Treatments With Nirogacestat Treatments With Nirogacestat
	10/7/2024	Lim, Allison	Assignor	Application Publication	18908159 20250025446	Treatments With Nirogacestat Treatments With Nirogacestat
	10/7/2024	Shearer, Todd Webster	Assignor	Application Publication	18908159 20250025446	Treatments With Nirogacestat Treatments With Nirogacestat
	10/7/2024	Williams, Rex	Assignor	Application Publication	18908159 20250025446	Treatments With Nirogacestat Treatments With Nirogacestat
	7/23/2024	Gwaltney, Stephen L	Assignor	Application Application Publication Publication	18247007 18247007 20240025856 20240025856	1,2,3,4-tetrahydroquinoline Derivatives As Inhibitors Of The Yap/taz-tea... 1,2,3,4-tetrahydroquinoline Derivatives As Inhibitors Of The Yap/taz-tea...
	7/23/2024	Gwaltney, Stephen L	Assignor	Application Publication	18145900 20230202985	Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD Indoles, Indazoles, and Related Analogs for Inhibiting YAP/TAZ-TEAD
	7/23/2024	Gwaltney, Stephen L, Ii	Assignor	Application Publication	18145986 20230279016	Tetrahydropyrazolopyrimidines and Related Analogs for Inhibiting YAP/TAZ... Tetrahydropyrazolopyrimidines and Related Analogs for Inhibiting YAP/TAZ...
	7/23/2024	The Board Of Trustees Of The Leland Stan...	Assignee	Application Publication	18701077 20240352021	Covalent Egfr Inhibitors And Methods Of Use Thereof Covalent Egfr Inhibitors And Methods Of Use Thereof
	7/23/2024	Gwaltney, Stephen L, Ii	Assignor	Application Publication	18665995 20240383891
	7/23/2024	Lawhorn, Brian	Assignor	Application Publication	18665995 20240383891
	7/10/2024	Gwaltney, Stephen Leycester, Ii	Assignor	Application Publication	18701077 20240352021	Covalent Egfr Inhibitors And Methods Of Use Thereof Covalent Egfr Inhibitors And Methods Of Use Thereof
	7/8/2024	Liu, Jiping	Assignor	Application Publication	18765632 20240358661	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	7/8/2024	Hatcher, Mark	Assignor	Application Publication	18765632 20240358661	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	7/8/2024	Patterson, Kristin	Assignor	Application Publication	18765632 20240358661	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	7/8/2024	Ruggiero, Piero L	Assignor	Application Publication	18765632 20240358661	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	7/8/2024	Iloeje, Uchenna H	Assignor	Application Publication	18765632 20240358661	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	7/8/2024	Langseth, Abraham J	Assignor	Application Publication	18765632 20240358661	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	6/6/2024	Patterson, Kristin	Assignor	Application Publication	18736140 20240316007	Compositions And Treatments With Nirogacestat Compositions And Treatments With Nirogacestat
	6/6/2024	Cheng, Shinta	Assignor	Application Publication	18736140 20240316007	Compositions And Treatments With Nirogacestat Compositions And Treatments With Nirogacestat
	6/6/2024	Shearer, Todd Webster	Assignor	Application Publication	18736140 20240316007	Compositions And Treatments With Nirogacestat Compositions And Treatments With Nirogacestat
	6/6/2024	Williams, Rex	Assignor	Application Publication	18736140 20240316007	Compositions And Treatments With Nirogacestat Compositions And Treatments With Nirogacestat
	6/5/2024	Gwaltney, Stephen L, Ii	Assignor	Application Publication	18734899 20250115574	2-pyrazole Anilines And Related Analogs For Inhibiting Yap/taz-tead 2-pyrazole Anilines And Related Analogs For Inhibiting Yap/taz-tead
	5/24/2024	Shearer, Todd	Assignor	Application Publication	18674104 20240307328	Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Iloeje, Uchenna H	Assignor	Application Publication	18674104 20240307328	Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Langseth, Abraham J	Assignor	Application Publication	18674104 20240307328	Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Shearer, Todd	Assignor	Application Publication	18674233 20240307330	Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Iloeje, Uchenna H	Assignor	Application Publication	18674233 20240307330	Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Langseth, Abraham J	Assignor	Application Publication	18674233 20240307330	Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Shearer, Todd	Assignor	Application Publication	18674168 20240307329	Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Iloeje, Uchenna H	Assignor	Application Publication	18674168 20240307329	Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Langseth, Abraham J	Assignor	Application Publication	18674168 20240307329	Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Shearer, Todd	Assignor	Application Publication Patent	18674233 20240307330 12220390	Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Iloeje, Uchenna H	Assignor	Application Publication Patent	18674233 20240307330 12220390	Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Langseth, Abraham J	Assignor	Application Publication Patent	18674233 20240307330 12220390	Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Shearer, Todd	Assignor	Application Publication Patent	18674168 20240307329 12257215	Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Iloeje, Uchenna H	Assignor	Application Publication Patent	18674168 20240307329 12257215	Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment
	5/24/2024	Langseth, Abraham J	Assignor	Application Publication Patent	18674168 20240307329 12257215	Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment
	4/28/2024	Shearer, Todd	Assignor	Application Publication	18648426 20250090484	Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi... Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi...
	4/28/2024	Iloeje, Uchenna H	Assignor	Application Publication	18648426 20250090484	Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi... Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi...
	4/28/2024	Langseth, Abraham J	Assignor	Application Publication	18648426 20250090484	Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi... Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi...
	4/28/2024	Shearer, Todd	Assignor	Application Publication Patent	18648426 20250090484 12295925	Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi... Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi... Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi...
	4/28/2024	Iloeje, Uchenna H	Assignor	Application Publication Patent	18648426 20250090484 12295925	Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi... Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi... Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi...
	4/28/2024	Langseth, Abraham J	Assignor	Application Publication Patent	18648426 20250090484 12295925	Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi... Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi... Treatment Of Neurofibromatosis Type 1 (nf1) Associated Plexiform Neurofi...
	4/3/2024	Patterson, Kristin	Assignor	Application Publication Patent	18624670 20240245648 12138246	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	4/3/2024	Cheng, Shinta	Assignor	Application Publication Patent	18624670 20240245648 12138246	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	4/3/2024	Lim, Allison	Assignor	Application Publication Patent	18624670 20240245648 12138246	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	4/3/2024	Shearer, Todd Webster	Assignor	Application Publication Patent	18624670 20240245648 12138246	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	4/3/2024	Williams, Rex	Assignor	Application Publication Patent	18624670 20240245648 12138246	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	4/1/2024	Liu, Jiping	Assignor	Application Patent	18608735 12029711	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Hatcher, Mark	Assignor	Application Patent	18608735 12029711	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Patterson, Kristin	Assignor	Application Patent	18608735 12029711	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Ruggiero, Piero L	Assignor	Application Patent	18608735 12029711	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Iloeje, Uchenna H	Assignor	Application Patent	18608735 12029711	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Langseth, Abraham J	Assignor	Application Patent	18608735 12029711	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Liu, Jiping	Assignor	Application Publication	18608748 20240307326	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Hatcher, Mark	Assignor	Application Publication	18608748 20240307326	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Patterson, Kristin	Assignor	Application Publication	18608748 20240307326	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Ruggiero, Piero L	Assignor	Application Publication	18608748 20240307326	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Iloeje, Uchenna H	Assignor	Application Publication	18608748 20240307326	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Langseth, Abraham J	Assignor	Application Publication	18608748 20240307326	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Liu, Jiping	Assignor	Application Publication	18608756 20240307327	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Hatcher, Mark	Assignor	Application Publication	18608756 20240307327	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Patterson, Kristin	Assignor	Application Publication	18608756 20240307327	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Ruggiero, Piero L	Assignor	Application Publication	18608756 20240307327	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Iloeje, Uchenna H	Assignor	Application Publication	18608756 20240307327	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	4/1/2024	Langseth, Abraham J	Assignor	Application Publication	18608756 20240307327	Dosage Forms Of Mirdametinib Dosage Forms Of Mirdametinib
	3/19/2024	Shearer, Todd	Assignor	Application Publication	18609687 20240216305	Mirdametinib Treatment Mirdametinib Treatment
	3/19/2024	Iloeje, Uchenna H	Assignor	Application Publication	18609687 20240216305	Mirdametinib Treatment Mirdametinib Treatment
	3/19/2024	Langseth, Abraham J	Assignor	Application Publication	18609687 20240216305	Mirdametinib Treatment Mirdametinib Treatment
	3/19/2024	Shearer, Todd	Assignor	Application Publication	18609768 20240216306	Mirdametinib Treatment Mirdametinib Treatment
	3/19/2024	Iloeje, Uchenna H	Assignor	Application Publication	18609768 20240216306	Mirdametinib Treatment Mirdametinib Treatment
	3/19/2024	Langseth, Abraham J	Assignor	Application Publication	18609768 20240216306	Mirdametinib Treatment Mirdametinib Treatment
	3/19/2024	Shearer, Todd	Assignor	Application Publication	18609727 20240226037	Mirdametinib Treatment Mirdametinib Treatment
	3/19/2024	Iloeje, Uchenna H	Assignor	Application Publication	18609727 20240226037	Mirdametinib Treatment Mirdametinib Treatment
	3/19/2024	Langseth, Abraham J	Assignor	Application Publication	18609727 20240226037	Mirdametinib Treatment Mirdametinib Treatment
	2/18/2024	Liu, Jiping	Assignor	Application Publication	18429056 20240216307	Dispersible Formulations Of N-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-... Dispersible Formulations Of N-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-...
	2/18/2024	Patterson, Kristin	Assignor	Application Publication	18429056 20240216307	Dispersible Formulations Of N-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-... Dispersible Formulations Of N-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-...
	1/26/2024	Gwaltney, Stephen L., Ii	Assignor	Application Publication Application	18145909 20230278982 12030866
	1/18/2024	Patterson, Kristin	Assignor	Application Publication Patent	18414185 20240189282 12186305	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	1/18/2024	Cheng, Shinta	Assignor	Application Publication Patent	18414185 20240189282 12186305	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	1/18/2024	Lim, Allison	Assignor	Application Publication Patent	18414185 20240189282 12186305	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	1/18/2024	Shearer, Todd Webster	Assignor	Application Publication Patent	18414185 20240189282 12186305	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	1/18/2024	Williams, Rex	Assignor	Application Publication Patent	18414185 20240189282 12186305	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	1/16/2024	Patheon Api Manufacturing Inc.	Assignor	Application Publication Application	18413575 20240190815 12240799
	1/16/2024	Catalent Pharma Solutions	Assignor	Application Publication Application	18413575 20240190815 12240799
	1/16/2024	Liu, Jiping	Assignor	Application Publication Application	18413575 20240190815 12240799
	1/16/2024	Patterson, Kristin	Assignor	Application Publication Application	18413575 20240190815 12240799
	1/16/2024	Patheon Api Manufacturing Inc.	Assignor	Application Publication Application	18413575 20240190815 12275688	Crystalline Solids Of Mek Inhibitor N-((r)-2,3-dihydroxypropoxy)-3,4-dif... Crystalline Solids Of Mek Inhibitor N-((r)-2,3-dihydroxypropoxy)-3,4-dif...
	1/16/2024	Catalent Pharma Solutions	Assignor	Application Publication Application	18413575 20240190815 12275688	Crystalline Solids Of Mek Inhibitor N-((r)-2,3-dihydroxypropoxy)-3,4-dif... Crystalline Solids Of Mek Inhibitor N-((r)-2,3-dihydroxypropoxy)-3,4-dif...
	1/16/2024	Liu, Jiping	Assignor	Application Publication Application	18413575 20240190815 12275688	Crystalline Solids Of Mek Inhibitor N-((r)-2,3-dihydroxypropoxy)-3,4-dif... Crystalline Solids Of Mek Inhibitor N-((r)-2,3-dihydroxypropoxy)-3,4-dif...
	1/16/2024	Patterson, Kristin	Assignor	Application Publication Application	18413575 20240190815 12275688	Crystalline Solids Of Mek Inhibitor N-((r)-2,3-dihydroxypropoxy)-3,4-dif... Crystalline Solids Of Mek Inhibitor N-((r)-2,3-dihydroxypropoxy)-3,4-dif...
	12/18/2023	Patterson, Kristin	Assignor	Application Publication Patent	18543022 20240148695 12036207	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	12/18/2023	Cheng, Shinta	Assignor	Application Publication Patent	18543022 20240148695 12036207	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	12/18/2023	Lim, Allison	Assignor	Application Publication Patent	18543022 20240148695 12036207	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	12/18/2023	Shearer, Todd Webster	Assignor	Application Publication Patent	18543022 20240148695 12036207	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	12/18/2023	Williams, Rex	Assignor	Application Publication Patent	18543022 20240148695 12036207	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Patterson, Kristin	Assignor	Application Application Publication Publication	18320547 18320591 20230372300 20230372301	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Cheng, Shinta	Assignor	Application Application Publication Publication	18320591 18320547 20230372300 20230372301	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Lim, Allison	Assignor	Application Application Publication Publication	18320547 18320591 20230372300 20230372301	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Shearer, Todd Webster	Assignor	Application Application Publication Publication	18320547 18320591 20230372301 20230372300	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Williams, Rex	Assignor	Application Application Publication Publication	18320547 18320591 20230372301 20230372300	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Patterson, Kristin	Assignor	Application Application Publication Publication Patent	18320547 18320591 20230372300 20230372301 11872211	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Cheng, Shinta	Assignor	Application Application Publication Publication Patent	18320547 18320591 20230372300 20230372301 11872211	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Lim, Allison	Assignor	Application Application Publication Publication Patent	18320547 18320591 20230372300 20230372301 11872211	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Shearer, Todd Webster	Assignor	Application Application Publication Publication Patent	18320547 18320591 20230372300 20230372301 11872211	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	10/15/2023	Williams, Rex	Assignor	Application Application Publication Publication Patent	18320547 18320591 20230372300 20230372301 11872211	Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat Treatments With Nirogacestat
	8/17/2023	Allogene Therapeutics, Inc.	Assignor	Application Publication	17758913 20230112444
	8/17/2023	Allogene Therapeutics, Inc.	Assignor	Application Publication	17758913 20230112444
	8/16/2023	Hatcher, Mark	Assignor	Application Publication	18304202 20230312480	Synthesis Of Nirogacestat Synthesis Of Nirogacestat
	8/16/2023	Patterson, Kristin	Assignor	Application Publication	18304202 20230312480	Synthesis Of Nirogacestat Synthesis Of Nirogacestat
	8/16/2023	Hatcher, Mark	Assignor	Application Publication Patent	18304202 20230312480 12234210	Synthesis Of Nirogacestat Synthesis Of Nirogacestat Synthesis Of Nirogacestat
	8/16/2023	Patterson, Kristin	Assignor	Application Publication Patent	18304202 20230312480 12234210	Synthesis Of Nirogacestat Synthesis Of Nirogacestat Synthesis Of Nirogacestat
	8/2/2023	Shearer, Todd	Assignor	Application Publication	18364058 20240000731	Non-linear Dosing Of Mirdametinib Non-linear Dosing Of Mirdametinib
	8/2/2023	Iloeje, Uchenna H	Assignor	Application Publication	18364058 20240000731	Non-linear Dosing Of Mirdametinib Non-linear Dosing Of Mirdametinib
	8/2/2023	Langseth, Abraham J	Assignor	Application Publication	18364058 20240000731	Non-linear Dosing Of Mirdametinib Non-linear Dosing Of Mirdametinib
	8/2/2023	Shearer, Todd	Assignor	Application Publication Patent	18364058 20240000731 12263146	Non-linear Dosing Of Mirdametinib Non-linear Dosing Of Mirdametinib Non-linear Dosing Of Mirdametinib
	8/2/2023	Iloeje, Uchenna H	Assignor	Application Publication Patent	18364058 20240000731 12263146	Non-linear Dosing Of Mirdametinib Non-linear Dosing Of Mirdametinib Non-linear Dosing Of Mirdametinib
	8/2/2023	Langseth, Abraham J	Assignor	Application Publication Patent	18364058 20240000731 12263146	Non-linear Dosing Of Mirdametinib Non-linear Dosing Of Mirdametinib Non-linear Dosing Of Mirdametinib
	7/24/2023	Shearer, Todd	Assignor	Application Publication	18357988 20240058282	Container Scheduling Container Scheduling
	7/24/2023	Iloeje, Uchenna H	Assignor	Application Publication	18357988 20240058282	Container Scheduling Container Scheduling
	7/24/2023	Langseth, Abraham J	Assignor	Application Publication	18357988 20240058282	Container Scheduling Container Scheduling
	5/13/2023	Shearer, Todd	Assignor	Application Application Publication Patent Patent	18186312 18185148 20230321013 11839595 11806322	Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment
	5/13/2023	Iloeje, Uchenna H	Assignor	Application Application Publication Patent Patent	18186312 18185148 20230321013 11839595 11806322	Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment
	5/13/2023	Langseth, Abraham J	Assignor	Application Application Publication Patent Patent	18185148 18186312 20230321013 11839595 11806322	Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment Mirdametinib Treatment

134 Rows Total

SpringWorks Therapeutics, Inc. has not been involved in any trademark assignment transactions in the PlainSite database.

Corporate Family (27)

Track Corporate Family

• Alban Carlos, None
• Ashar Bhavesh, None
• Burgess Michael F., None
• Cassidy, James, None
• Edris, Badreddin, None
• Francis Perier I Jr, None
• Fuhrman Alan, None
• Gordon Carl L, None
• Greco Michael V., None
• Hambleton, Julie, None
• Islam Saqib, None
• Koppel, Adam, None
• Lewis-Hall Freda C, None
• Lin, Tai-an, None
• Lynch, Daniel, None
• Mackay Martin, None
• Nofi Michael, None
• Orbimed Advisors, LLC, None
• OrbiMed Capital GP VI LLC, None
• Patrick Deval L, None
• Pfizer Ventures (US) LLC, None
• Pichl Daniel, None
• Renstrup Jens, None
• Schwartz Jeffrey Lawrence, None
• Smith, L. Mary, None
• Squinto, Stephen P., None
• Weinstein Herschel S, None

Subsidiaries

• Schwartz Jeffrey Lawrence
• Squinto, Stephen P.
• Lewis-Hall Freda C
• Lynch, Daniel
• Fuhrman Alan
• Pfizer Ventures (US) LLC
• Koppel, Adam
• OrbiMed Capital GP VI LLC
• Nofi Michael
• Weinstein Herschel S
• Hambleton, Julie
• Pichl Daniel
• Edris, Badreddin
• Renstrup Jens
• Francis Perier I Jr
• Smith, L. Mary
• Islam Saqib
• Patrick Deval L
• Gordon Carl L
• Greco Michael V.
• Orbimed Advisors, LLC
• Ashar Bhavesh
• Burgess Michael F.
• Alban Carlos
• Cassidy, James
• Lin, Tai-an
• Mackay Martin

Sign in to add additional links.

Incoming Payments

This organization has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This organization has not disclosed any outgoing payments to lobbying groups.